<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Lambert | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/menubeauty2/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/menubeauty2/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lambert.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">999fac9decf3f92fe8c2f9257245b392</guid>
				<title>Lambert posted an update: Neonatal infection, a leading cause of neonatal death in [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42241/</link>
				<pubDate>Sun, 09 Feb 2025 08:32:53 -0800</pubDate>

									<content:encoded><![CDATA[<p>Neonatal infection, a leading cause of neonatal death in low- and middle-income countries, is often caused by pathogens acquired during childbirth. Clean delivery kits (CDKs) have shown efficacy in reducing infection-related perinatal and neonatal mortality. However, there remain gaps in our current knowledge, including the effect of individual&hellip;<span class="activity-read-more" id="activity-read-more-42241"><a href="http://www.nationalboardinstitute.com/activity/p/42241/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">db47b1553481b92bdcd966fabfb87a42</guid>
				<title>Lambert posted an update: s a direct and functional target of miR-146b-3p. check [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40626/</link>
				<pubDate>Fri, 07 Feb 2025 08:39:17 -0800</pubDate>

									<content:encoded><![CDATA[<p>s a direct and functional target of miR-146b-3p. <a href="https://www.selleckchem.com/products/en450.html" rel="nofollow ugc">check details</a> CircTMOD3 regulated LPS-induced cell inflammation and injury by targeting miR-146b-3p, and miR-146b-3p-mediated suppression of CXCR1 impacted LPS-evoked cytotoxicity and inflammation. Furthermore, circTMOD3 functioned as a competing endogenous RNA (ceRNA) for miR-146b-3p to induce&hellip;<span class="activity-read-more" id="activity-read-more-40626"><a href="http://www.nationalboardinstitute.com/activity/p/40626/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">906b1422e5ace27c356b10e61f021ba8</guid>
				<title>Lambert posted an update: The TMP recovery rate of PEG-MWCNT membrane after cross [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37921/</link>
				<pubDate>Tue, 04 Feb 2025 08:39:56 -0800</pubDate>

									<content:encoded><![CDATA[<p>The TMP recovery rate of PEG-MWCNT membrane after cross flushing was 79.4%, while that of raw MWCNT-COOH and MWCNT membrane were only 14.9% and 28.3%, respectively. PEG non-covalent functionalization improved the antifouling ability of the raw MWCNT membranes and reduced the irreversible fouling, which effectively prolonged the service life of&hellip;<span class="activity-read-more" id="activity-read-more-37921"><a href="http://www.nationalboardinstitute.com/activity/p/37921/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5db86ec80e9cde838252b2eb79f29fc6</guid>
				<title>Lambert posted an update: Most methods that model 3D porous media from 2D images are [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36977/</link>
				<pubDate>Mon, 03 Feb 2025 08:31:51 -0800</pubDate>

									<content:encoded><![CDATA[<p>Most methods that model 3D porous media from 2D images are based on binary images. In this paper, we propose a method for reconstructing 3D greyscale isotropic porous media images from a single image. Our proposed method incorporates a fast-sampling procedure to control the continuity and variability between adjoining reconstruction layers, a new&hellip;<span class="activity-read-more" id="activity-read-more-36977"><a href="http://www.nationalboardinstitute.com/activity/p/36977/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1d52bf0bc7fb3b4bfccf6293d928f24f</guid>
				<title>Lambert posted an update: , our packing method, which uses Merocel and Nasopore [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35157/</link>
				<pubDate>Sat, 01 Feb 2025 08:26:34 -0800</pubDate>

									<content:encoded><![CDATA[<p>, our packing method, which uses Merocel and Nasopore simultaneously, can be recommended because it can provide sufficient support for the reduced fracture site, cause less pain, and maximize discharge absorption.</p>
<p> The reconstruction of nasal alar defects after resection of a melanocytic nevus becomes one of the most challenging procedures for&hellip;<span class="activity-read-more" id="activity-read-more-35157"><a href="http://www.nationalboardinstitute.com/activity/p/35157/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">af2c4f3747b56758c4a9e34e5f41b08c</guid>
				<title>Lambert posted an update: Two anti-FXIIa agents namely tick protein Ir-CPI and [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33210/</link>
				<pubDate>Thu, 30 Jan 2025 08:28:45 -0800</pubDate>

									<content:encoded><![CDATA[<p>Two anti-FXIIa agents namely tick protein Ir-CPI and monoclonal antibody CSL312 are currently in human clinical trials. The results of these trials and further studies of FXII(a) pathophysiological functions will encourage the development of new FXII(a) inhibitors.Brain drug delivery remains a major difficulty for several challenges including the&hellip;<span class="activity-read-more" id="activity-read-more-33210"><a href="http://www.nationalboardinstitute.com/activity/p/33210/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c899bfeb977d21616abf3e762a27447e</guid>
				<title>Lambert posted an update: Underlying signaling pathways involve phosphoinositide [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28102/</link>
				<pubDate>Tue, 28 Jan 2025 10:31:34 -0800</pubDate>

									<content:encoded><![CDATA[<p>Underlying signaling pathways involve phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin, extracellular signal-regulated kinase 1/2, and inositol requiring kinase 1α/XBP1/C/EBP homologous protein. Herein, we discuss the role of apelin/APJ axis and associated molecular mechanisms on the pathogenesis of PD in vitro and in vivo and&hellip;<span class="activity-read-more" id="activity-read-more-28102"><a href="http://www.nationalboardinstitute.com/activity/p/28102/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c83826b3f55a8840c083713b6f441916</guid>
				<title>Lambert became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28044/</link>
				<pubDate>Tue, 28 Jan 2025 10:28:22 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>